Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Shares Issued (2021 - 2025)

Bioventus (BVS) has disclosed Shares Issued for 5 consecutive years, with $511000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued fell 53.67% year-over-year to $511000.0, compared with a TTM value of $2.1 million through Dec 2025, down 15.07%, and an annual FY2025 reading of $2.1 million, down 15.07% over the prior year.
  • Shares Issued was $511000.0 for Q4 2025 at Bioventus, up from $96000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $110.4 million in Q2 2021 and bottomed at -$107.0 million in Q4 2021.
  • Average Shares Issued over 5 years is $5.9 million, with a median of $496500.0 recorded in 2022.
  • The sharpest move saw Shares Issued plummeted 98.99% in 2022, then skyrocketed 598.1% in 2024.
  • Year by year, Shares Issued stood at $107.0 million in 2021, then tumbled by 98.99% to $1.1 million in 2022, then plummeted by 85.41% to $158000.0 in 2023, then surged by 598.1% to $1.1 million in 2024, then plummeted by 53.67% to $511000.0 in 2025.
  • Business Quant data shows Shares Issued for BVS at $511000.0 in Q4 2025, $96000.0 in Q3 2025, and $1.3 million in Q2 2025.